Información de la revista
Vol. 33. Núm. 4.Julio 2013
Páginas 443-622
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 33. Núm. 4.Julio 2013
Páginas 443-622
DOI: 10.3265/Nefrologia.pre2013.Apr.11914
Acceso a texto completo
Pregnancy in patient with cirrhosis and cryoglobulinemic vasculitis
Pregnancy in patient with cirrhosis and cryoglobulinemic vasculitis
Visitas
4071
Gioacchino Li Cavolia, Carlo Giammarresia, Calogera Tortoricia, Luisa Bonoa, Angelo Ferrantellia, Ugo Rotoloa
a Division of Nephrology, Civic and Di Cristina Hospital, Palermo, Italy,
Este artículo ha recibido
4071
Visitas
Información del artículo
Texto completo
Descargar PDF
Estadísticas
Texto completo

Dear Editor,

Pregnancy is a rare event in patients with cirrhosis1 and women with hepatitis have an increased risk of complications during pregnancy.2,3 There are few reports on this topic. The cryoglobulinemic vasculitis associated with HCV infection is a severe systemic disease involving the kidneys; it develops due to deposits of cryoglobulins. The course is often fatal or leads to end-stage renal disease. The disease tends to relapse. Women with this disorder rarely become pregnant and conclude successfully the pregnancy.

Our experience: a 30-year-old woman suffering from HCV-cirrhosis was admitted for severe peripheral edema with proteinuria 7g/day and albumin 2.3g/dL. The glomerular filtration rate was in the normal range. Renal biopsy showed a membranous-proliferative glomerulonephritis.

The patient received 1 cycle of 12 plasmapheresis associated with Mycophenolate Mofetil (MM) 2g/day and prednisone 12.5mg/day therapy. After 1 month, we observed a partial remission of proteinuria (3g/day). The MM therapy was continued. After 2 years, the patient reported amenorrhea lasting for 3 months. The beta-HCG test and U.S. scan confirmed the pregnancy. The MM was interrupted whereas prednisone therapy was maintained at 5mg/day. During pregnancy, proteinuria was always less than 2g/day and renal function was regular. The pregnancy continued without major problems. A cesarean section was performed at the thirty-sixth week of pregnancy. Laboratory tests showed: white blood cells: 3.170/mmc, Hb: 8.2g/dL. PLT: 46.000/mmc, AST: 60IU/L, ALT 33IU/L, gammaGT: 14IU/L, total bilirubine: 1.84mg/dL, total protein: 4.1g/dL, albumin: 2.16g/dL. The fetus was healthy and growth corresponded to the twenty-eighth week of pregnancy. Anti-HCV antibodies detection was negative and the child follow-up did not show any significant diseases after 3 years from birth. The patient resumed MM and prednisone therapy. One year after the child's birth, the patient showed good health with proteinuria 1g/day; she continued MM 2g/day and prednisone 5mg/day. After 18 months postpartum, proteinuria increased to 4g/day. We carried out again a cycle of six plasmapheresis, achieving a reduction of proteinuria (<1g/day). Therefore, we carried out the maintenance of MM and prednisone therapy at the same dose. Although pregnancy in patient with cirrhosis remains rare, recent improvements in the treatment of cirrhosis led to an increase in life expectancy and quality of life, making pregnancy a most frequent event. Outcomes of pregnancy in patients with cirrhosis are poorly described. Regarding neonatal well-being, there is no association between vertical transmission of HCV and gestational age at delivery or the presence of chorioamnionitis. There is no evidence demonstrating an increased risk of HCV transmission in HIV-negative women who breast feed.4 There are some reports regarding a worsening of HCV-liver disease after pregnancy.5 Regarding immunological pathology, the prognosis associated with many forms of systemic vasculitides was quite grim. Advances in this field have allowed us to focus on issues related to quality of life such as fertility, conception, and pregnancy among women with vasculitis.6 This case report shows the possibility of a favourable outcome, if the pregnancy occurs during a clinical stabilization phase of cirrhosis and vasculitis.

 

Conflict of interest

 

The authors declare that they have no conflicts of interest related to the contents of this article.

Idiomas
Nefrología

Suscríbase a la newsletter

Opciones de artículo
Herramientas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.